Kyle Bryant was diagnosed with Friedreich's Ataxia, or FA, at 17 years old. Friedreich's Ataxia is a a rare neuromuscular disease that affects 1 in 50,000 people. Over the last ...

Eleven foals in the Pacific Northwest were diagnosed with a condition called Equine Juvenile Spinocerebellar Ataxia (EJSCA).

Solid Biosciences Inc.’s SLDB share price has dipped by 14.97%, which has investors questioning if this is right time to buy.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Biogen enhances its portfolio and margins amidst market challenges and competition. Click here to find out why BIIB stock is ...

Yoda Therapeutics Inc. (YODA), an AI-driven company that focuses on Central Nervous System (CNS) drugs, today announced the dosing of the first patient in the Phase 2 trial of YA-101 for Multiple ...

Single IV administration of tau silencing gene therapy VY1706 significantly reduced tau mRNA and protein levels, with broad brain distribution and liver ...

Lexeo Therapeutics, Inc.’s LXEO share price has dipped by 10.14%, which has investors questioning if this is right time to buy.

Lexeo Therapeutics (NASDAQ:LXEO – Get Free Report) had its price objective dropped by Leerink Partners from $19.00 to $18.00 ...

Investment analysts at Leerink Partnrs dropped their FY2025 earnings estimates for shares of Lexeo Therapeutics in a report ...